ライフサイエンスコーパス: hospitalize

1 180 days; 2,490 (52%) were never previously hospitalized.

2 th RSV illness, males were more likely to be hospitalized.

3 nt infection; 7 reported symptoms and 3 were hospitalized.

4 rged from the ED and 608% for those who were hospitalized.

5 ubated, 627 (25%) died, and 59 (2%) remained hospitalized.

6 ted after seven days in 17/23 patients still hospitalized.

7 18 to $92 151 per member) for those who were hospitalized.

8 Most patients were hospitalized, 12.1% in intensive care units, and 17.6% n

9 atients [7.6%]); among the patients who were hospitalized, 20 (40.8%) were admitted to an intensive c

10 d 240 case-patients from 37 states; 104 were hospitalized, 28 developed hemolytic uremic syndrome, an

11 dents with SARS-CoV-2 infection, 11 had been hospitalized (3 in the intensive care unit) and 15 had d

12 Among those hospitalized (376 [78%]), 117 (31%) required mechanical

13 % of patients were hospitalized: among those hospitalized, 47.5% were admitted to an intensive care u

14 Sixteen patients died (18% overall, 24% of hospitalized, 52% of ICU) and 37 (54%) were discharged.

15 id-19-positive patients (1382 patients) were hospitalized, 76.9% of whom were black.

16 Hospitalized acutely ill medical patients are at risk fo

17 er intravenous NAC hastens liver recovery in hospitalized adult patients with anti-tuberculosis drug

18 tional, retrospective cohort study involving hospitalized adult patients with confirmed, mild to seve

19 Eligible Covid-19 cases were non-hospitalized adult patients with recently confirmed SARS

20 We randomly assigned hospitalized adult patients with severe Covid-19 pneumon

21 This is a cohort study of all hospitalized adult patients, from January 2009 to Decemb

22 Unformed stool specimens from 200 hospitalized adults (100 PCR positive and 100 negative)

23 Of the 11 066 tested persons, 115 (1%) were hospitalized adults investigated for COVID-19.

24 In hospitalized adults with Covid-19, no significant reduct

25 In hospitalized adults with COVID-19, remdesivir probably i

26 Hospitalized adults with laboratory-confirmed MERS were

27 icenter (n = 14), observational study of 265 hospitalized adults with MRSA bacteremia treated with va

28 d more than six times as likely to have been hospitalized after a suicide attempt.

29 -PCR or antibody testing, and 164 (88%) were hospitalized after April 16, 2020.

30 cost and epidemiology of sepsis in patients hospitalized after trauma.

31 We identified hospitalized AMI among members >=35 years of age in Kais

32 Overall, 95.9% of patients were hospitalized: among those hospitalized, 47.5% were admit

33 nosed through 12 March, by 30 March 13% were hospitalized and 2% died.

34 rate was 22.3% (n = 25); 72.3% (n = 81) were hospitalized and 26.8% (n = 30) admitted to the intensiv

35 nrolled and submitted a stool specimen (2187 hospitalized and 4767 in the ED).

36 sponsible for the recent global outbreaks in hospitalized and long-term care patients with significan

37 ing assays reliably detect SARS-CoV-2 Abs in hospitalized and nonhospitalized patients and are theref

38 e fully recovered off oxygen, 2/7 were still hospitalized, and 1/7 had died.

39 osing, 17/23 were recovered, 2/23 were still hospitalized, and 4/23 had died.

40 (27/286) overall, 16.5% (27/164) among those hospitalized, and 51.5% (24/47) among those admitted to

41 fully recovered from COVID-19, 77 (21%) were hospitalized, and 9 (2%) died.

42 ion rate than the general population that is hospitalized, and even moderate reductions in kidney fun

43 severe RSV infection, the majority of those hospitalized are previously healthy infants.

44 14 among otherwise healthy 29-34 wGA infants hospitalized at <6 months of age.

45 d alive, 178 (29%) died and 55 (9%) remained hospitalized at censoring.

46 estimate the proportion of febrile children hospitalized at the study hospitals.

47 nts with hospitalization data available were hospitalized (Bangladesh, 27% [1295/4868]; Nepal, 29% [4

48 until 4 years of age, at which point she was hospitalized because of three syncopal episodes that wer

49 Among hospitalized beneficiaries, the risk-adjusted 30-day mor

50 38 veterans with critical limb ischemia were hospitalized between 2005 and 2014.

51 Subjects included hospitalized children with >= 1 antibiotic order at 8:00

52 use of acute respiratory infections (ARI) in hospitalized children.

53 ental disorder at all time points versus the hospitalized cohort (year 5: adjusted hazard ratio, 2.00

54 al injury and associated outcomes in a large hospitalized cohort with laboratory-confirmed COVID-19.

55 omes were similar to those reported in other hospitalized cohorts.

56 Recent reports identify that among hospitalized coronavirus disease 2019 patients, 30% requ

57 In this prospective cohort study of 39 hospitalized coronavirus disease COVID-19 patients, we d

58 aboratory-diagnosed COVID-19 cases and (iii) hospitalized COVID-19 cases.

59 e outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demograph

60 Hospitalized COVID-19 patients developed higher IgG conc

61 In this multi-center cohort of hospitalized COVID-19 patients in the largest health sys

62 135 hospitalized COVID-19 patients were compared with 184 hi

63 tibody, compared with a negative group of 43 hospitalized COVID-19 patients, finding association with

64 ed with lower mortality and intubation among hospitalized COVID-19 patients.

65 RS-CoV-2 viral load (SARS-CoV-2 RNAaemia) in hospitalized COVID-19 patients.

66 categorization and disease phenotyping among hospitalized COVID-19 patients.

67 dengue-naive and 89.2% (82.4 - 93.3) against hospitalized dengue.

68 A substantial minority of patients hospitalized develop an acute COVID-19 cardiovascular sy

69 Of the positive persons, 7292 were hospitalized directly upon presentation; an additional 8

70 Across all ages, men are more likely to be hospitalized, enter intensive care, and die than women.

71 of patients with COVID-19, and 20% of those hospitalized, experience severe symptoms necessitating i

72 itiation of sacubitril/valsartan in patients hospitalized for acute decompensated heart failure (ADHF

73 eness of the PIONEER-HF trial among patients hospitalized for ADHF using real-world data.

74 routinely considered for patients with HFrEF hospitalized for ADHF.

75 of 21 [20-22] y, 2131 participants had been hospitalized for any PAD.

76 biotic therapy for at least 2 days, and were hospitalized for at least 3 days after starting antibiot

77 or older, able to read and write Italian and hospitalized for at least 3 days.

78 Among 842 infants hospitalized for bronchiolitis, there was 88% follow-up

79 d clinical data and nasal swabs from infants hospitalized for bronchiolitis.

80 group and 6 (14%) in the control group were hospitalized for cellulitis (hazard ratio, 0.38; 95% CI,

81 2, 1.3% (95% CI = 0.9-1.6%, I(2) = 87%) were hospitalized for cerebrovascular events, 1.1% (95% CI =

82 from fee-for-service Medicare beneficiaries hospitalized for COPD in 2014, at 4446 acute care hospit

83 Admission suPAR levels in patients hospitalized for COVID-19 are predictive of in-hospital

84 cal ventilation and mortality among patients hospitalized for COVID-19, regardless of LVEF.

85 ents with hematological malignancies who are hospitalized for cytotoxic chemotherapy in noncritical c

86 g tests administered to 1,746 pregnant women hospitalized for delivery between March 22nd and May 3rd

87 patients post-MI, of which 33 patients were hospitalized for HF (median follow-up, 2.0 years), was u

88 Of the 25,345 older patients hospitalized for HF in the Medicare-linked OPTIMIZE-HF (

89 nresponders were those who either died, were hospitalized for HF, or had <5-point improvement in KCCQ

90 centrations were higher in patients who were hospitalized for longer, supporting the recent observati

91 The majority of patients hospitalized for new-onset HF did not receive testing fo

92 All patients were aged >=65 and hospitalized for new-onset HF from 2009 to 2015.

93 infarction on postoperative day 5 and 1 was hospitalized for observation following hematemesis of ol

94 32 moderate-to-severe patients with COVID-19 hospitalized for pneumonia and longitudinally followed f

95 Of 122 infants hospitalized for RV bronchiolitis (median age, 4 months)

96 Among patients hospitalized for SCC, 30-day readmissions were frequent

97 ients with opioid use disorder (OUD) who are hospitalized for serious infections requiring prolonged

98 ple living with human immunodeficiency virus hospitalized for severe acute respiratory syndrome coron

99 to receive antibiotics (47% of whom were not hospitalized for the index treatment) and 776 to undergo

100 expression profiles among patients with SCD hospitalized for VOC and ACS episodes to better understa

101 d 18-80 years) of Central and South Auckland hospitalized for World Health Organization-defined sever

102 h type 2 diabetes mellitus who were recently hospitalized for worsening heart failure were randomly a

103 tients 65 years of age or older who had been hospitalized from 2006 to 2017.

104 For rural Medicare beneficiaries hospitalized from 2007 to 2017, CAHs submitted significa

105 The study assessed patients hospitalized from January 2016 through March 2017 that w

106 ase or HF who had data on GlycA and incident hospitalized HF.

107 controlled trial evaluating the LAM test in hospitalized HIV-infected patients with suspected TB.

108 Hospitalized immunocompromised (IC) adults with influenz

109 Using data from patients hospitalized in a cohort of 890 U.S. hospitals during th

110 strain cultured from the urine of a patient hospitalized in the greater Houston metropolitan region

111 onfirmed coronavirus disease 2019 (COVID-19) hospitalized in the Kaiser Permanente Northern Californi

112 ommunity-associated MRSA is increasing among hospitalized individuals in Ontario.

113 nt knowledge base, addressing separately (1) hospitalized individuals with rest congestion, where dia

114 specific humoral responses in a cohort of 22 hospitalized individuals.

115 The 1-year cumulative incidence of hospitalized infection in Optum patients not receiving g

116 , <=5 mg/d, >5 to 10 mg/d, and >10 mg/d) and hospitalized infection were evaluated using inverse prob

117 Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials in outpatients ha

118 is a major preventable disease that affects hospitalized inpatients.

119 In sum, hospitalized kidney transplant recipients with COVID-19

120 n hospitalized patients than in patients not hospitalized (log10 VL = 3.3 versus 4.0; P = 0.018) afte

121 ys of illness onset, 1544 (81%) of 1906 were hospitalized (median duration, 6 days; range, 0-50), and

122 y prognostic factors for VTE and bleeding in hospitalized medical patients and searched Medline and E

123 informs risk prediction in the management of hospitalized medical patients for VTE and bleeding; it a

124 Analyses were performed for hospitalized MM patients.

125 Adults with chronic kidney disease (CKD) are hospitalized more frequently than those without CKD, but

126 central nervous system (CNS) infection among hospitalized neonates and young infants, yet testing for

127 d (CSF) samples in children impacted care of hospitalized neonates and young infants.

128 In a predominantly hospitalized New York City cohort, elderly patients are

129 with influenza may have worse outcomes than hospitalized non-IC adults.

130 ated in an emergency department, 1 (<1%) was hospitalized; none died.

131 ensive care cohort and 84.7% of those in the hospitalized nonintensive care setting.

132 RSV infection in hospitalized older adults often manifested as severe, li

133 Hospitalized older patients not taking diuretics prior t

134 Of 34 927 children hospitalized on survey days, 12 213 (35.0%) had >= 1 act

135 limited mobility including patients that are hospitalized or obese.

136 data from 2012 to 2016 for patients who were hospitalized or who died after >=1 dose of isoniazid-rif

137 ntilator-associated pneumonia, are common in hospitalized patient populations.

138 In the hospitalized patient study, acute inflammatory condition

139 Over half of hospitalized patients (8/14) were discharged home.

140 rtality within 30 days after an alert) among hospitalized patients (excluding those in the ICU) whose

141 Results The cohort included 356 hospitalized patients (mean age, 69 years +/- 12 [standa

142 Among hospitalized patients 65 years or younger with severe CO

143 andardized dose on the risk of HO-CDI within hospitalized patients administered antibiotics frequentl

144 s In this retrospective observational study, hospitalized patients aged 18 years or younger with stab

145 ere related or not related to drug use among hospitalized patients aged 18-55 years based on retrospe

146 njury occurs in approximately one-quarter of hospitalized patients and is associated with a greater n

147 Hypokalemia occurs in up to 20% of hospitalized patients and is associated with increased i

148 e that 30%-50% of antibiotics prescribed for hospitalized patients are inappropriate, but pediatric d

149 ate the risk of acute kidney injury (AKI) in hospitalized patients based on admission serum ionized c

150 The study included all sequentially hospitalized patients between March 1, 2020, and April 4

151 e Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies.

152 Beside respiratory insufficiency, many hospitalized patients exhibit neurological manifestation

153 rculosis to reduce AIDS Related Mortality in hospitalized Patients in Africa [STAMP] trial).

154 on in total MRSA acquisitions in a cohort of hospitalized patients in the year following their index

155 ery, and reduce serious adverse events among hospitalized patients not requiring mechanical ventilati

156 All hospitalized patients received hydroxychloroquine and az

157 A 40.6% subgroup of hospitalized patients required neither ICU or hospital-r

158 Diagnostic VL was significantly lower in hospitalized patients than in patients not hospitalized

159 ize antibiotic overuse after discharge among hospitalized patients treated for pneumonia or urinary t

160 Hospitalized patients treated with chloroquine/hydroxych

161 We retrospectively analyzed 34,630 hospitalized patients undergoing native renal biopsy bet

162 sistance profiles of bacterial infections of hospitalized patients using machine learning algorithms

163 ung disease, was associated with death among hospitalized patients warrants further investigation, as

164 of therapeutic agents, we randomly assigned hospitalized patients who had Covid-19 without end-organ

165 mdesivir, did not demonstrate efficacy among hospitalized patients who had Covid-19 without end-organ

166 All hospitalized patients who received a blood culture durin

167 Among 1438 hospitalized patients with a diagnosis of COVID-19 (858

168 In sputum-expectorating hospitalized patients with advanced HIV and access to bo

169 re have been no direct comparisons of AKI in hospitalized patients with and without COVID-19 that wou

170 Diagnosis of EE in hospitalized patients with candidemia.

171 We identified 98 783 hospitalized patients with candidemia; 529 patients (0.5

172 ters that prospectively enrolled nonelective hospitalized patients with cirrhosis (n = 726).

173 est this hypothesis, we collected urine from hospitalized patients with community-acquired pneumonia

174 teristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New

175 necrosis factor (TNF)-alpha and IL-1beta in hospitalized patients with coronavirus disease 2019 (COV

176 ficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Cov

177 AKI is common among hospitalized patients with coronavirus disease 2019 (COV

178 Of 725 consecutive hospitalized patients with coronavirus disease 2019, 108

179 ission was predictive of critical illness in hospitalized patients with coronavirus disease 2019.

180 levation, and associated outcomes among U.S. hospitalized patients with coronavirus disease-2019 (COV

181 Abnormal liver tests occur in most hospitalized patients with COVID-19 and may be associate

182 However, AKI among hospitalized patients with COVID-19 in the United States

183 intes was observed in 1 (0.015%) out of 6476 hospitalized patients with COVID-19 receiving hydroxychl

184 The risk of torsade de pointes is low in hospitalized patients with COVID-19 receiving hydroxychl

185 The overall prevalence of asthma among all hospitalized patients with COVID-19 was 12.6%, yet a hig

186 normal liver tests were commonly observed in hospitalized patients with COVID-19, both at admission (

187 at admission to predict critical illness in hospitalized patients with COVID-19.

188 ransfusion of convalescent plasma is safe in hospitalized patients with COVID-19.TRIAL REGISTRATIONCl

189 perspective on initial outcomes observed in hospitalized patients with diabetes and the potential ro

190 mental health conditions, were common among hospitalized patients with EVALI.

191 Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry, 9,86

192 s to identify predictors of ICU admission in hospitalized patients with hematologic malignancies.

193 Hospitalized patients with hospital-acquired/ventilator-

194 study was to describe the characteristics of hospitalized patients with InfA infections during an ent

195 ng 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19

196 We randomly assigned 800 hospitalized patients with medically and socially comple

197 tudy (9 countries, 25 centers) including 767 hospitalized patients with P. aeruginosa bacteremia trea

198 Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infe

199 s retrospective study, all consecutive adult hospitalized patients with polymerase chain reaction pos

200 , to April 24, 2020, a consecutive cohort of hospitalized patients with real-time reverse transcripti

201 r, prospective, observational study of adult hospitalized patients with SAB.

202 Background The prognosis of hospitalized patients with severe coronavirus disease 20

203 thma was associated with poor outcomes among hospitalized patients with severe COVID-19 compared with

204 ble-blind, randomized trial, we recruited 88 hospitalized patients with SIAD-induced hyponatremia <13

205 yndrome, myocarditis, and potential MIS-C in hospitalized patients younger than 21 years of age and s

206 cluded (14 of 34 adult studies included only hospitalized patients).

207 Among the 68 hospitalized patients, 12% required non-rebreather and 3

208 esistance results of bacterial cultures from hospitalized patients, alongside their electronic medica

209 al diagnosis; 82.4% of biopsies were done in hospitalized patients, and 65% of the lesions were locat

210 the most commonly administered antibiotic in hospitalized patients, but optimal exposure targets rema

211 atologic malignancy and COVID-19, especially hospitalized patients, have a high risk of dying.

212 t and reporting the level of VTE risk in all hospitalized patients, integrating preventable VTE as a

213 Among hospitalized patients, males produce stronger SARS-CoV-2

214 Of 197 hospitalized patients, the mean (SD) age of the cohort w

215 Among hospitalized patients, the median age was 69 years, and

216 fm) is the driver for E. faecium carriage in hospitalized patients, which, in turn, is a risk factor

217 0/286) of all patients and 30.5% (50/164) of hospitalized patients.

218 robial-resistant opportunistic infections in hospitalized patients.

219 sed for similar indication in this cohort of hospitalized patients.

220 documenting a positive IgG response in all 7 hospitalized patients.

221 phic variability, ranging from 27% to 57% of hospitalized patients.

222 rates of severe disease and mortality in our hospitalized patients.

223 ic stewardship has focused overwhelmingly on hospitalized patients.

224 nce interval [CI], 579,125 to 665,655) among hospitalized patients.

225 he primary endpoint, 28-day mortality, among hospitalized patients.

226 associated with DHF/Severe dengue disease in hospitalized pediatric patients.

227 jiLAM with Xpert for tuberculosis testing in hospitalized people with HIV is likely to increase life

228 e and relative burden of comorbidities among hospitalized PLHIV is changing over time.

229 Poor outcomes for hospitalized PLWH were frequent but similar to proportio

230 However, studies focus mainly on hospitalized populations.

231 rted data span March 21 to June 16, 2020 for hospitalized pregnant women with PCR-confirmed SARS-CoV-

232 ce interval: 0.53 to 0.99) to patients never hospitalized (rate ratio: 1.00; 95% confidence interval:

233 RSV-positive children were more likely to be hospitalized, require intensive care unit (ICU) admissio

234 23 hospitalized severe/critical COVID-19 patients received

235 as performed to analyze MIC gene profiles in hospitalized Thai children with acute dengue illness.

236 individuals with PID, 53.3% (32 of 60) were hospitalized, the infection-fatality ratio was 20.0% (12

237 s than those with PID; 75.8% (25 of 33) were hospitalized, the infection-fatality ratio was 33.3% (11

238 e ranged from 0% among 79 persons previously hospitalized to 11.0% among 308 persons with asymptomati

239 diagnostic and/or treatment procedures among hospitalized U.S. adults, 18-64 years, with primary diag

240 ifficile is the leading cause of diarrhea in hospitalized U.S. patients and results in over 400,000 c

241 72% of nonbacteremic CAP cases obtained from hospitalized US adults.

242 IS) was queried for all patients with cancer hospitalized with a diagnosis of brain metastases.

243 45 064 patients (13 878 [30.8%] women) were hospitalized with a primary diagnosis of first-time MI (

244 hospitalist, reflect on the care of a woman hospitalized with a rheumatologic disorder.

245 spectively (2018-2019) patients who had been hospitalized with a similar clinico-biological picture.

246 diatric solid organ transplant recipients is hospitalized with a vaccine-preventable infection in the

247 Focused questions in adults hospitalized with acute severe ulcerative colitis includ

248 my is particularly high among those patients hospitalized with acute severe ulcerative colitis.

249 3006 persons aged 75 years or older who were hospitalized with AMI and discharged alive.

250 up period of a prospective study of patients hospitalized with an acute myocardial infarction.

251 from retrospective cohorts of pregnant women hospitalized with ARFI who had testing for influenza vir

252 retrospective cohort study of adult patients hospitalized with bacterial pneumonia who achieved clini

253 Approximately 3% of patients hospitalized with brain metastases also had a diagnosis

254 variability and clinical severity in infants hospitalized with bronchiolitis over 6 epidemic seasons

255 Patients hospitalized with confirmed COVID-19 infection between M

256 Participants hospitalized with COPD exacerbations were assigned 1:1 t

257 AKI is common among patients hospitalized with COVID-19 and is associated with high m

258 In-person communication with patients hospitalized with COVID-19 and their families is often n

259 We analyzed data from patients hospitalized with COVID-19 at 88 US hospitals enrolled i

260 Patients hospitalized with COVID-19 had a higher incidence of sev

261 r venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.

262 Retrospective studies of patients hospitalized with COVID-19 in Wuhan, China, report an in

263 b in patients from these populations who are hospitalized with Covid-19 pneumonia are unclear.

264 More than 75% of patients hospitalized with COVID-19 require supplemental oxygen.

265 De novo treatment with RAASi in patients hospitalized with COVID-19 should be prospectively inves

266 Blood samples from adult patients hospitalized with COVID-19 were analyzed using high-thro

267 were obtained regarding consecutive patients hospitalized with Covid-19, excluding those who were int

268 Among patients hospitalized with Covid-19, those who received hydroxych

269 sed risk of in-hospital death among patients hospitalized with Covid-19.

270 d associated outcomes among patients with HF hospitalized with COVID-19.

271 onal registry capturing consecutive patients hospitalized with COVID-19.

272 effect of this antibody in patients who are hospitalized with Covid-19.

273 cal data on 59 patients on dialysis who were hospitalized with COVID-19.

274 e randomized clinical trial including adults hospitalized with gram-negative bacteremia conducted in

275 function allowed categorization of patients hospitalized with HF and predicted all-cause mortality i

276 y as a predictor of recovery in older adults hospitalized with influenza and acute respiratory illnes

277 In this population-based study of adults hospitalized with influenza, almost 12% of patients had

278 idity and mortality occurred among IC adults hospitalized with influenza.

279 017, 10 patients in the Sacramento area were hospitalized with laboratory-confirmed botulism; 7 requi

280 We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our h

281 We identified adults hospitalized with laboratory-confirmed influenza during

282 with higher risk for aHF and aIHD in adults hospitalized with laboratory-confirmed influenza.

283 r-ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS

284 Among patients hospitalized with mild-to-moderate Covid-19, the use of

285 PWID hospitalized with other infections acted as a novel comp

286 study demonstrates that urine from patients hospitalized with pneumonia may serve as a reliable and

287 Adults hospitalized with respiratory symptoms from severe acute

288 There were 664 patients hospitalized with RSV (61% female, 64% aged >=75 years).

289 for severe disease, the majority of infants hospitalized with RSV are previously healthy.

290 ation costs for 2090 adults aged >= 60 years hospitalized with RSV or influenza by assigning direct h

291 screened all consecutive adults (>=18 years) hospitalized with SAB at three Mayo Clinic sites between

292 ficant changes in hospital costs in patients hospitalized with sepsis in New York State.

293 egulations on the costs of care for patients hospitalized with sepsis.

294 Nasal aspirates were collected from infants hospitalized with severe (admitted to the pediatric ICU)

295 Children who have been hospitalized with severe anemia in areas of Africa in wh

296 study included 540 older adults who had been hospitalized with severe TBI over the 10-year period; 42

297 asal aspirates of young children (<=3 years) hospitalized with viral respiratory infection (n = 138)

298 The number of patients hospitalized with worsening HF or diagnosed with new-ons

299 ents with sacubitril/valsartan from patients hospitalized within 30 days (rate ratio: 0.73; 95% confi

300 with chronic life-limiting illness who were hospitalized within 6 months of death, treatment-limitin